Walgreens nabs $100M BARDA partnership to expand decentralized clinical trials

Wal­greens has snagged US gov­ern­ment fund­ing to ex­pand its clin­i­cal tri­al ca­pa­bil­i­ties, con­tin­u­ing in­vest­ment where oth­ers have dropped off.

The re­tail phar­ma­cy is part­ner­ing with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.